Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Charlesworth Group (USA)

Charlesworth Press is located in Wakefield, West Yorkshire, UK. Printing operations are situated alongside our bindery division, Hammonds for maximum efficiency. Continuous investment means the Charlesworth’s services continue to develop in order to serve the changing needs of our clients. Our press room and bindery remain equipped with the latest machinery to deliver rapid turnaround yet still provide the best possible quality services at competitive prices.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications Logo

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Advertising, Branding, Conference/meetings/events, Creative and design, Digital communications, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Sales, Training

- PMLiVE

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Sales

Company Details

The Charlesworth Group (USA)
3624 Market St 5E, Philadelphia, Pennsylvania, 19104, United States
(00) +1 2159221611
Contact The Charlesworth Group (USA)
Website

 Latest Content from PMHub 

The speed of science and the pace of comms

White Papers and Resources | March 30, 2023 | Fox&Cat

Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes.

Virtual Patient Engagement Program: A Customer Story

White Papers and Resources | March 27, 2023 | Impetus Digital

Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease...

Putting Skin in the Game at AAD 2023

Press Releases | March 27, 2023 | Medscape Education

AAD has wrapped up in New Orleans, and the Medscape team have returned home from another successful conference.During the conference, Medscape hosted one educational symposium, Reframing the Management Approach for...

Humancomms for humancare?

White Papers and Resources | March 27, 2023 | Fox&Cat

Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023

Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery

Videos and Podcasts | March 23, 2023 | Impetus Digital

Dr. Shahar Keinan, Co-founder & CEO of POLARIS Quantum Biotech, explores quantum computing and AI for drug discovery, the Quantum Molecular Design process, and how POLARISqb is working to improve...

Wrapping up EAU with a Look at Medscape’s Urology Impact

Press Releases | March 23, 2023 | Medscape Education

The Medscape Education Global team has returned from EAU in Milan, Italy, having presented an educational symposium and a networking event with Urology faculty and supporters.The educational symposium, Harnessing the...

Webcast: Evolving Patient Journeys – How to generate deeper insights in a changing healthcare landscape

White Papers and Resources | March 21, 2023 | Inizio

Watch part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years.

How to create content for health professionals

Press Releases | March 20, 2023 | Springer Nature

Catching the attention of time-strapped healthcare professionals is hard, but not impossible.

The challenges of reimbursement and innovative pricing for cell and gene therapies

White Papers and Resources | March 16, 2023 | Avalere Health

Our policy and market access experts at Avalere, part of Fishawack Health, share insights on the reimbursement challenges for cell and gene therapies and discuss the challenges and opportunities of...

Digital therapeutics as a combination therapy: Maximizing asset value and therapeutic outcomes

White Papers and Resources | March 16, 2023 | Avalere Health

Digital therapeutics can increase the value of medicinal assets, driving differentiation and improving outcomes for patients. But are manufacturers prepared to capitalize on this significant untapped opportunity before the tech...